rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial

OBJECTIVE: To investigate recombinant human insulin-like growth factor 1 complexed with its binding protein (rhIGF-1/rhIGFBP-3) for the prevention of retinopathy of prematurity (ROP) and other complications of prematurity among extremely preterm infants. STUDY DESIGN: This phase 2 trial was conducte...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pediatr
Asıl Yazarlar: Ley, David, Hallberg, Boubou, Hansen-Pupp, Ingrid, Dani, Carlo, Ramenghi, Luca A., Marlow, Neil, Beardsall, Kathryn, Bhatti, Faizah, Dunger, David, Higginson, Jason D., Mahaveer, Ajit, Mezu-Ndubuisi, Olachi J., Reynolds, Peter, Giannantonio, Carmen, van Weissenbruch, Mirjam, Barton, Norman, Tocoian, Adina, Hamdani, Mohamed, Jochim, Emily, Mangili, Alexandra, Chung, Jou-Ku, Turner, Mark A., Smith, Lois E. H., Hellström, Ann
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389415/
https://ncbi.nlm.nih.gov/pubmed/30471715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2018.10.033
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller